Randomized Phase III Trial Assessing Regional Lung Function for Thoracic Resection by Hyperpolarized 129Xenon Gas MRI

被引:3
|
作者
Shim, Yun [1 ]
Mata, Jaime [1 ]
Hartwig, Matthew [2 ]
Aragaki-Nakahodo, Alejandro [3 ]
West, Ken [4 ]
Emami, Kiarash [4 ]
Wadehra, Neil [4 ]
Cleveland, Zackary [5 ]
Walkup, Laura [5 ]
Woods, Jason [5 ]
Dusek, Alex [4 ]
Mugler, John [1 ]
Driehuys, Bastiaan [2 ]
机构
[1] Univ Virginia, Charlottesville, VA USA
[2] Duke Univ, Durham, NC 27706 USA
[3] Univ Cincinnati, Cincinnati, OH USA
[4] Polarean Inc, Durham, NC USA
[5] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
关键词
Diagnosis; Lung cancer - management; Physiological diagnostic services;
D O I
10.1183/13993003.congress-2020.2080
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
2080
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Split course versus continuous thoracic radiotherapy (TRT) for limited stage small cell lung cancer (L-SCLC): A randomized phase III trial
    Matthews, C
    Bogart, J
    White, D
    Case, LD
    Miller, A
    Blackstock, AW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S203 - S203
  • [42] High-dose vs standard-dose thoracic radiotherapy for extensive stage small cell lung cancer: Study protocol for a phase III randomized trial
    Yang, Y.
    Bi, N.
    Jiang, W.
    Hu, X.
    Zhao, L.
    Zhang, L.
    Wang, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S1170 - S1171
  • [43] Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer
    Hideki Kimura
    Yukiko Matsui
    Aki Ishikawa
    Takahiro Nakajima
    Toshihiko Iizasa
    Cancer Immunology, Immunotherapy, 2018, 67 : 1231 - 1238
  • [44] Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer
    Kimura, Hideki
    Matsui, Yukiko
    Ishikawa, Aki
    Nakajima, Takahiro
    Iizasa, Toshihiko
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (08) : 1231 - 1238
  • [45] CAPTAIN STUDY: ASSOCIATION OF MODERATE AND SEVERE ASTHMA EXACERBATIONS WITH LUNG FUNCTION AND PATIENT-REPORTED OUTCOMES IN A LARGE RANDOMIZED PHASE III CLINICAL TRIAL
    Sule, Neal
    Fowler, Andrew
    Kerstjens, Huib
    Kerwin, Edward
    Lee, Laurie
    Nathan, Robert
    Oppenheimer, John
    Pavord, Ian
    Peachey, Guy
    Tabberer, Maggie
    Zarankaite, Agne
    Manning, Michael
    Millard, Mark
    Mannino, David
    Hanania, Nicola
    CHEST, 2020, 158 (04) : 35A - 38A
  • [46] THORACIC RADIATION-THERAPY ALONE COMPARED WITH COMBINED CHEMORADIOTHERAPY FOR LOCALLY UNRESECTABLE NON-SMALL CELL LUNG-CANCER - A RANDOMIZED, PHASE-III TRIAL
    MORTON, RF
    JETT, JR
    MCGINNIS, WL
    EARLE, JD
    THERNEAU, TM
    KROOK, JE
    ELLIOTT, TE
    MAILLIARD, JA
    NELIMARK, RA
    MAKSYMIUK, AW
    DRUMMOND, RG
    LAURIE, JA
    KUGLER, JW
    ANDERSON, RT
    ANNALS OF INTERNAL MEDICINE, 1991, 115 (09) : 681 - 686
  • [47] An international, randomized, phase III trial of bacillus Calmette-Guerin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites
    Morton, D. L.
    Mozzillo, N.
    Thompson, J. F.
    Kelley, M. C.
    Faries, M.
    Wagner, J.
    Schneebaum, S.
    Schuchter, L.
    Gammon, G.
    Elashoff, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol
    Deng, Lei
    Shayan, Gulidanna
    Jiang, Wei
    Bi, Nan
    Wang, Luhua
    THORACIC CANCER, 2024, 15 (11) : 938 - 943
  • [49] Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer
    Shimokawa, Tsuneo
    Yamada, Kazuhiko
    Tanaka, Hiroshi
    Kubota, Kaoru
    Takiguchi, Yuichi
    Kishi, Kazuma
    Saito, Haruhiro
    Hosomi, Yukio
    Kato, Terufumi
    Harada, Daijiro
    Otani, Sakiko
    Kasai, Takashi
    Nakamura, Yoichi
    Misumi, Toshihiro
    Yamanaka, Takeharu
    Okamoto, Hiroaki
    CANCER MEDICINE, 2021, 10 (02): : 626 - 633
  • [50] Protocol digest of a phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery-hyperintense lesion on MRI for newly diagnosed supratentorial glioblastoma: JCOG2209 (FLAMINGO)
    Sekino, Yuta
    Sonoda, Yukihiko
    Shibahara, Ichiyo
    Mizusawa, Junki
    Sasaki, Keita
    Sekita, Tetsuya
    Ichikawa, Mayumi
    Igaki, Hiroshi
    Kinoshita, Manabu
    Kumabe, Toshihiro
    Shibahara, Junji
    Ichimura, Koichi
    Arakawa, Yoshiki
    Fukuda, Haruhiko
    Narita, Yoshitaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 55 (01) : 75 - 79